Background
==========

Asthma and chronic obstructive pulmonary disease (COPD) are the most common airway disorders with a high morbidity and mortality \[[@B1],[@B2]\]. According to the Global Initiative for Asthma (GINA), approximately 300 millions people suffer from asthma \[[@B1]\] with a prevalence ranging from 1 to 18%. COPD prevalence is around 6%, but data are highly variable, depending on survey methods and diagnostic criteria \[[@B3]\].

Both asthma and COPD are characterized by inflammation, which in asthma, particularly the eosinophilic phenotype, is predominantly confined to the airway, while in COPD the inflammation may spill-over from the lungs to the systemic circulation and initiate systemic inflammation, as a consequence of exposure to indoor or outdoor air pollution, cigarette smoke, or diesel exhaust fumes \[[@B4]\]. A recent observation indicates that patients with neutrophilic asthma often have systemic inflammation \[[@B5]\]. Elevated serum levels of reactive C-reactive protein (CRP) are considered markers of systemic inflammation either in COPD or in asthma \[[@B5],[@B6]\]. Systemic inflammation may be pathogenically related to many of the comorbidities seen in chronic obstructive airway diseases, including cardiovascular disease (CVD). Cardiovascular complications in COPD have been attributed to the systemic effects of smoking \[[@B7]\]. Several observations suggest that reduced pulmonary function, no matter what cause, is associated with increases in myocardial infarction and arrhythmia \[[@B8]-[@B11]\]. Forced expiratory volume in one second (FEV~1~) is ranked second to smoking and above blood pressure and cholesterol as a predictor of all-cause and cardiovascular mortality \[[@B12]\]. In this regard, it has been suggested that a reduction in FEV~1~ combined with smoking history better predicts cardiovascular mortality than cholesterol \[[@B13]\].

The aim of this study was to evaluate prevalence and predictors of CVD in two common airway obstructive diseases with quite different phenotypes, asthma and COPD.

Methods
=======

Consecutive adults outpatients with asthma and COPD, diagnosed according to international guidelines \[[@B1],[@B2]\], were recruited from those attending the Respiratory Pathophysiology clinic of the University Hospital San Giovanni, Turin, Italy, between January 2011 and June 2012. Inclusion criteria were: age over 40 years, no acute exacerbation of COPD and asthma in the last two months, no active pulmonary tuberculosis or other clinically relevant lung disease. Patients aged below 40 years were excluded because in this age range the risk of COPD is low \[[@B14]\].

Study design
------------

Patients underwent recording of demographic data including age, full smoking history (current, former and never-smokers), recording of symptoms and medication use, clinical examination, assessment of lung function tests, arterial blood gas analysis and venous blood sampling for serum determination of CRP. Body mass index was calculated on the basis of height and weight (BMI) \[[@B15]\]. Asthma and COPD severity were classified according to GINA \[[@B1]\] and GOLD \[[@B2]\] criteria, respectively. Among COPD patients, those with predominant chronic bronchitis and predominant emphysema were identified.

Coexistent cardiovascular disease was assessed on the basis of history, clinical and echocardiographic data. CVD included: prior myocardial infarction and cardiovascular accidents, documented ischaemic heart disease, pulmonary or systemic arterial hypertension, heart valve disease, echocardiographic diagnosis of pulmonary hypertension.

According to the criteria of the American Heart Association \[[@B16]\], heart disease was classified as follows:

-- pressure overload (PO), causing diastolic dysfunction with preserved systolic function, including all the conditions causing concentric left ventricle hypertrophy, such as systemic arterial hypertension and aortic valve disease

-- volume overload (VO), including all the conditions causing left ventricle dilatation and systolic dysfunction, such as mitral or aortic incompetence and ischemic heart disease.

Sub-analysis was done on patients with ischemic heart disease (IHD) and pulmonary hypertension (PH).

Lung function tests were measured using the Baires System (Biomedin, Padua, Italy). The values of vital capacity (VC), forced expiratory volume in one second (FEV~1~), and their percentage ratio (FEV~1~/VC%), and maximum expiratory flow at mid VC (MEF~50~) were computed and expressed as percentage of the predicted value, according to the European Respiratory Society guidelines \[[@B17]\].

Arterial blood gases, that is oxygen and carbon dioxide partial pressures (PaO~2~ and PaCO~2~ respectively) were measured using the analyzer GEM 4000 PREMIERE (Instrumentation Laboratory Lexington USA).

Statistical analysis
--------------------

Data were analyzed using the SPSS software package, version 20.0 (SPSS Inc., Chicago, IL, USA) for Windows. Discrete variables are presented as counts and percentages. Continuous variables are presented as means ± SEM, as appropriate. Comparisons between asthmatics and COPD patients, and between patients with predominant chronic bronchitis and predominant emphysema were performed by the unpaired Student\'s *t*-test. Comparisons among CVD, PO and VO patients with univariate ANOVA. Nominal variables were compared with the Fisher\'s exact test and Pearson's *χ*^2^. A stepwise backward selection procedure was used to evaluate factors influent on heart disease, using a linear regression models. The models had as dependent variables CVD, PO or VO and as independent predictors: disease (asthma or COPD), age, sex, BMI, smoking habits, GINA or GOLD class, prebronchodilator lung function tests, PaO~2~, CRP. The same models were used to evaluate predictors for asthma and COPD separately and for the sub-analysis of patients with IHD or PH.

Statistical significance was assumed at p \< 0.05.

Results
=======

The subjects enrolled were 100 asthmatic patients and 129 COPD patients. CVD was found in 185 patients (81%), and consisted of pressure overload in 97 (42%) and of volume overload in 88 (38%). IHD was found in 58 patients (25%), 8 asthmatics and 50 COPD, and PH in 25 (11%), all with COPD. The general characteristics of asthmatic and COPD patients are compared in Table [1](#T1){ref-type="table"}. The COPD group was older, and had higher prevalence of men and of both present and past smokers, more severe airway obstruction and higher prevalence of heart disease, including PO, VO, IHD and PH. Moreover, COPD patients had higher CRP values than asthmatics, suggestive of systemic inflammation. No significant difference in PaO~2~ and PaCO~2~ was found between the two groups.

###### 

Comparison between general characteristics of patients with asthma and with COPD

                                    **ASTHMA N. 100**   **COPD N. 129**     **P**
  -------------------------------- ------------------- ----------------- -----------
  Age, years                            59 ± 1.1           69 ± 0.9       \< 0.0001
  BMI                                  25.6 ± 0.5         26.2 ± 0.45       0.010
  Male, n (%)                           22 (22.0)          78 (60.5)      \< 0.0001
  Smokers                                                                      
    current, n (%)                       10 (10)           72 (55.8)      \< 0.0001
    past, n (%)                           8 (8)            42 (32.6)      \< 0.0001
  Atopy,n (%)                           65 (73.1)          10 (7.7)       \< 0.0001
  Cardiovascular disease, n (%)          68 (68)          117 (90.7)       0.00002
    Pressure overload, n (%)            38 (38.0)          59 (45.7)         NS
    Volume overload, n (%)              30 (30.0)          58 (45.0)        0.021
    Subgroup IHD, n (%)                  8 (8.0)           50 (38.8)      \< 0.001
    Subgroup PH, n (%)                   0 (0.0)           25 (19.4)      \< 0.001
  VC\*, % predicted                    88.9 ± 1.7         83.6 ± 1.8        0.033
  FEV~1~\*, % predicted                78.0 ± 2.0         64.6 ± 1.9      \< 0.0001
  FEV~1~/VC\* %                        65.7 ± 1.3         57.1 ± 1.3      \< 0.0001
  MEF~50~\*, % predicted               41.8 ± 2.4         29.5 ± 2.1      \< 0.0001
  PaO~2~ , mmHg                        74.5 ± 1.6         71.4 ± 1.0         NS
  PaCO~2~ , mmHg                       38.4 ± 0.5         39.8 ± 0.5         NS
  CRP, mg/ml                            3.4 ± 0.4          7.6 ± 0.7      \< 0.0001
  Beta adrenergic therapy, n (%)        94 (94.9)          97 (75.2)       0.0001
  Corticosteroid therapy, n (%)          95 (96)           90 (69.8)      \< 0.0001
  Anticholinergic therapy, n (%)         22 (22)           76 (58.9)      \<0.0001

Value recorded before bronchodilator.

The comparisons among subgroups with no cardiovascular disease (No CVD), with PO and VO in the overall patients, in asthma and in COPD are reported in the Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}.

###### 

Comparisons among patients without cardiovascular disease (no CVD), with pressure overload (PO) and volume overload (VO) in the overall study population

  **ASTHMA + COPD**    **no CVD N. 44**   **PO N. 97**   **VO N. 88**   **Univariate ANOVA**   **no CVD vs PO**   **no CVD vs VO**   **PO vs VO**
  ------------------- ------------------ -------------- -------------- ---------------------- ------------------ ------------------ --------------
  Age, years              53.3 ± 1.3       64.3 ± 1.0     69.1 ± 1.1         \< 0.0001            \< 0.0001          \< 0.0001          0.002
  Male, n (%)             18 (40.9)        43 (44.3)      39 (44.3)              NS                   NS                 NS               NS
  BMI                     24.7 ± 0.7       26.9 ± 0.6     25.5 ± 0.5           0.038                0.028                NS               NS
  VC, % pred.             93.4 ± 2.2       85.1 ± 1.7     83.5 ± 2.4           0.011                0.005              0.006              NS
  FEV~1,~ % pred.         82.6 ± 2.5       70.7 ± 2.1     64.8 ± 2.4         \< 0.0001              0.001            \< 0.0001            NS
  FEV~1~/VC %             67.6 ± 1.7       61.5 ± 1.5     56.7 ± 1.6         \< 0.0001              0.015            \< 0.0001          0.032
  MEF~50,~ % pred         49.5 ± 4.1       35.8 ± 2.3     25.8 ± 2.3         \< 0.0001              0.002            \< 0.0001          0.003
  CRP, mg/ml              3.1 ± 0.6         5.9± 0.6      7.3 ± 1.0            0.011                0.009              0.007              NS

*NS* not statistically significant.

###### 

Comparisons among patients without cardiovascular disease (no CVD), with pressure overload (PO) and volume overload (VO) in asthma

  **ASTHMA**         **no CVD N. 32**   **PO N. 38**   **VO N. 30**   **Univariate ANOVA**   **no CVD vs PO**   **no CVD vs VO**   **PO vs VO**
  ----------------- ------------------ -------------- -------------- ---------------------- ------------------ ------------------ --------------
  Age, years            51.3 ± 1.4       60.7 ± 1.6     63.1 ± 2.1         \< 0.0001            \< 0.0001          \< 0.0001            NS
  Male, n (%)            9 (28.1)         6 (15.8)       7 (23.3)              NS                   NS                 NS               NS
  BMI                   24.5 ± 0.8       26.5 ± 0.9     25.7 ± 0.7             NS                   NS                 NS               NS
  VC, % pred.           94.0 ± 2.8       84.7 ± 2.2     89.0 ± 3.7             NS                 0.011                NS               NS
  FEV~1,~ % pred.       85.4 ± 2.9       76.7 ± 2.9     73.8 ± 4.5           0.029                0.041              0.032              NS
  FEV~1~/VC %           68.9 ± 1.7       65.7 ± 2.0     61.2 ± 2.9           0.042                  NS               0.010              NS
  MEF~50,~ % pred       51.3 ± 4.2       37.8 ± 3.5     35.8 ± 4.5           0.017                0.016              0.015              NS
  CRP, mg/ml            2.5 ± 0.5        4.1 ± 0.8      3.5 ± 0.8              NS                   NS                 NS               NS

###### 

Comparisons among patients without cardiovascular disease (no CVD), with pressure overload (PO) and volume overload (VO) in COPD

  **COPD**           **no CVD N. 12**   **PO N. 59**   **VO N. 58**   **Univariate ANOVA**   **no CVD vs PO**   **no CVD vs VO**   **PO vs VO**
  ----------------- ------------------ -------------- -------------- ---------------------- ------------------ ------------------ --------------
  Age, years            58.5 ± 2.6       66.7 ± 1.3     72.4 ± 1.0         \< 0.0001              0.012            \< 0.0001          0.001
  Male, n (%)             9 (75)         37 (62.7)      32 (55.2)              NS                   NS                 NS               NS
  BMI                   25.4 ± 1.5       27.1 ± 0.7     25.4 ± 0.6             NS                   NS                 NS               NS
  VC, % pred.          91.8 ± 3.12       85.3 ± 2.4     80.0 ± 2.9             NS                   NS                 NS               NS
  FEV~1,~% pred         75.2 ± 4.8       66.3 ± 2.8     60.1 ± 2.8           0.048                  NS               0.023              NS
  FEV~1~/VC %           61.5 ± 3.8       58.8 ± 2.0     54.4 ± 1.9             NS                   NS                 NS               NS
  MEF~50,~ % pred      44.6 ± 10.2       34.5 ± 3.1    20.18 ± 2.1         \< 0.0001                NS             \< 0.0001        \< 0.0001
  CRP, mg/ml            4.4 ± 1.4        7.0 ± 0.9      8.9 ± 1.4              NS                   NS                 NS               NS

In the overall patients (Table [2](#T2){ref-type="table"}), both PO and VO, as compared with no CVD, were associated with older age and lower VC, FEV~1~, FEV~1~/VC and MEF~50~ and higher CRP. The same associations (apart from CRP) were found in asthmatic patients (Table [3](#T3){ref-type="table"}). In COPD patients (Table [4](#T4){ref-type="table"}) the significant associations were with age and MEF~50,~ %.

The results of linear regression analysis are shown in Table [5](#T5){ref-type="table"} for the whole patients, in Table [6](#T6){ref-type="table"} for asthmatic patients and in Table [7](#T7){ref-type="table"} for COPD patients. In the overall patients predictive factors of CVD were: age, COPD, and sex; those of PO were COPD, BMI, VC, FEV~1~ and MEF~50~ and those of VO were age, class of disease severity, VC and MEF~50~. In asthma, the strongest predictors of CVD were VC, FEV~1~ and FEV~1~ /VC%, and PaO~2~, those of PO were VC, FEV~1~ and FEV~1~ /VC%; no predictor was found for VO. In COPD the predictors of CVD were age, GOLD class and sex; those of VO were age, VC and MEF~50~, while the only predictor of PO was BMI.

###### 

Results of linear regression analysis for predictors of cardiovascular disease (CVD) in the overall patients

  **Asthma + COPD**    **Non standardized coefficients**   **Standardized coefficient**   **t**   **Sig.**  
  ------------------- ----------------------------------- ------------------------------ ------- ---------- ------
  CVD                                                                                                          
  Constant                           .948                              .248                        3.829     .000
  Age                                .012                              .003               .340     4.357     .000
  COPD                               .137                              .063               .169     2.195     .030
  Sex                                .116                              .058               .144     1.991     .048
  VC, % pred                         -.003                             .002               -.124    −1.784    .076
  MEF~50~, % pred                    -.002                             .001               -.131    −1.728    .086
  Pressure overload                                                                                            
  Constant                           1.066                             .264                        4.031     .000
  COPD                               .217                              .074               .225     2.939     .004
  BMI                                .017                              .007               .183     2.482     .014
  VC, % pred                         -.006                             .003               -.213    −2.031    .044
  FEV~1~, % pred                     .007                              .003               .322     2.162     .032
  MEF~50~, % pred                    -.006                             .002               -.305    −2.668    .008
  Volume Overload                                                                                              
  Constant                           1.318                             .446                        2.954     .004
  Age                                .015                              .004               .310     3.529     .001
  GINA/GOLD class                    -.118                             .056               -.227    −2.113    .037
  VC, % pred                         -.006                             .003               -.197    −2.244    .027
  MEF~50~, % pred                    -.005                             .002               -.227    −2.094    .038

###### 

Results of linear regression analysis for predictors of cardiovascular diseases (CVD) in asthma

  **ASTHMA**           **Non standardized coefficients**   **Standardized coefficient**   **t**    **Sig.**  
  ------------------- ----------------------------------- ------------------------------ -------- ---------- ------
  CVD                                                                                                           
  Constant                           8.291                            1.056                         7.851     .000
  Age                                -.009                             .005               -.270     −1.981    .059
  BMI                                .016                              .008                .223     1.874     .073
  VC, % pred                         −.060                             .009               −2.402    −6.630    .000
  FEV~1~, % pred                     .073                              .011               3.667     6.894     .000
  FEV~1~/VC, %                       −.094                             .013               −3.499    −7.021    .000
  PaO~2~                             −.010                             .005               −.278     −2.268    .033
  PRC                                .016                              .009                .209     1.797     .085
  Pressure Overload                                                                                             
  Constant                           6.668                            1.082                         6.163     .000
  VC, % pred                         −.060                             .012               −1.874    −5.078    .000
  FEV~1~, % pred                     .067                              .013               2.626     5.107     .000
  FEV~1~/VC, %                       −.077                             .016               −2.237    −4.690    .000
  Volume Overload                                                                                               
  Constant                           −.116                             .693                         −.167     .869
  Age                                .019                              .011                .320     1.822     .079

###### 

Results of linear regression analysis for predictors of cardiovascular diseases (CVD) in COPD

  **COPD**             **Non standardized coefficients**   **Standardized coefficient**   **t**   **Sig.**  
  ------------------- ----------------------------------- ------------------------------ ------- ---------- ------
  CVD                                                                                                          
  Constant                           .686                              .393                        1.747     .084
  Age                                .007                              .003               .228     2.143     .035
  GOLD Class                         .076                              .036               .241     2.089     .040
  Sex                                .121                              .061               .203     1.983     .050
  PaO~2~                             .006                              .003               .209     1.826     .071
  Pressure Overload                                                                                            
  Constant                           1.237                             .229                        5.414     .000
  BMI                                .020                              .008               .244     2.337     .022
  Volume Overload                                                                                              
  Constant                           1.317                             .519                        2.539     .013
  Age                                .017                              .005               .334     3.311     .001
  VC, % pred                         −.006                             .003               −.220    −2.076    .041
  MEF~50~, % pred                    −.006                             .003               −.305    −2.351    .021

As shown in Table [8](#T8){ref-type="table"}, the predictors of IHD were COPD, age, BMI and FEV~1~ and those of PH, found only in COPD patients, were VO (present in 80% of the patients) and FEV~1~.

###### 

Results of linear regression analysis for predictors of ischemic heart disease (IHD) and pulmonary hypertension (PH)

  **IHD**           **Non standardized coefficients**   **Standardized coefficient**   **t**   **Sig.**  
  ---------------- ----------------------------------- ------------------------------ ------- ---------- ------
  IHD                                                                                                       
  Constant                       −1.486                             .667                        −2.229    .028
  COPD                            .450                              .134               .412     3.351     .001
  Age                             .012                              .004               .246     2.834     .005
  BMI                             .016                              .008               .177     2.095     .038
  FEV~1~, % pred                  .007                              .003               .309     2.127     .036
  GOLD class                      .150                              .083               .294     1.810     .073
  PH                                                                                                        
  Constant                        1.127                             .244                        4.613     .000
  VO                              .246                              .045               .442     5.468     .000
  GOLD class                      −.105                             .041               −.273    −2.584    .011
  FEV~1~, % pred                  −.004                             .002               −.239    −2.222    .028

The distributions of PO and VO by severity of asthma (GINA) and COPD (GOLD) are reported in Figure [1](#F1){ref-type="fig"}. In asthma, there is a clear increase in the prevalence of both PO and VO with increasing the severity class, while in COPD the prevalence of each type of CVD is similar in all classes. The comparison between chronic bronchitis and emphysema patients, shown in Table [9](#T9){ref-type="table"}, showed that the latter ones had older age, lower BMI, more severe airway obstruction and higher prevalence of heart volume overload and of pulmonary hypertension.

![Distributions of heart pressure overload (PO) and volume overload (VO) by GINA asthma severity class (left graph), and by GOLD COPD severity class (right graph).](2049-6958-8-58-1){#F1}

###### 

Comparison between general characteristics of patients with chronic bronchitis and emphysema

  --------------------------------------------------------------------------------------
                                   **Chronic bronchitis**\   **Emphysema**\     **P**
                                         **N. 102**            **N. 27**     
  ------------------------------- ------------------------- ---------------- -----------
  Age, years                              68 ± 1.0              73 ± 1.5        0.017

  BMI                                    27.2 ± 0.5            22.1 ± 0.6     \< 0.0001

  Male, n (%)                             58 (56.9)            20 (74.1)         NS

  Smokers                                                                          

    current, n (%)                        55 (53.9)             17 (63)          NS

    past, n (%)                           33 (32.4)             9 (33.3)         NS

  Cardiovascular disease, n (%)           92 (90.2)            25 (92.6)         NS

  Pressure overload,n (%)                  51 (50)              8 (29.6)         NS

  Volume overload, n (%)                  41 (40.2)             17 (63)         0.034

  Subgroup IHD n (%)                      39 (39.4)            11 (40.7)         NS

  Subgroup PH n (%)                       15 (4.7)              10 (37)         0.009

  GOLD class                                                                       

    1                                     30 (29.4)             1 (3.7)         0.005

    2                                     44 (43.1)             8 (29.6)         NS

    3                                     19 (18.6)            13 (48.1)       0.0016

    4                                      9 (8.8)              5 (18.5)         NS

  VC, % predicted                          82.7 ±2             85.5 ± 4.3        NS

  FEV~1~, % predicted                     68.1± 2.2            51.9 ± 3.1       0.001

  FEV~1~/VC %                            60.2 ± 1.4           46.56 ± 2.6     \< 0.0001

  MEF~50~, % predicted                   33.7 ± 2.5            13.6 ± 2.1     \< 0.0001

  PaO~2~ , mmHg                          71.2 ± 1.1            70.1 ± 2.1        NS

  PaCO~2\ ,~ mmHg                        40.1 ± 0.6            39.0 ± 0.8        NS

  CRP, mg/ml                              7.9 ± 1.0            6.8 ± 1.2         NS
  --------------------------------------------------------------------------------------

As one of the stronger predictors of CVD was age, we made a sub-analysis on subjects with an age equal to 65 years or higher. As shown in Table [10](#T10){ref-type="table"}, the prevalence of CVD, PO and VO was similar in asthmatic and COPD patients; the latter had higher prevalence of men, smokers, lower FEV~1~, higher CRP and of IHD and PH. The results of linear regression analysis in these older patients are reported in Tables [11](#T11){ref-type="table"}, [12](#T12){ref-type="table"} and [13](#T13){ref-type="table"}.

###### 

Comparisons between general characteristics of patients 65 years old or more

                                   **ASTHMA N. 33**   **COPD N. 92**     **P**
  ------------------------------- ------------------ ---------------- -----------
  Age, years                          71.8 ± 0.8        73.6 ± 0.6        NS
  Male, n (%)                          5 (15.2)         60 (65.2)      \< 0.0001
  Smokers                                                                   
  Current n(%)                          4 (13)           45 (51)       \< 0.0001
  Past n (%)                            4 (13)           36 (41)       \< 0.0001
  BMI                                 25.8 ± 0.8        26.2 ± 0.5        NS
  CVD, n (%)                          30 (90.9)         87 (94.6)         NS
  Pressure overload, n (%)            15 (45.5)         38 (41.3)         NS
  Volume overload, n (%)              15 (45.5)         49 (53.3)         NS
  Ischemic heart disease, n (%)        6 (18.2)         42 (46.7)       0.0054
  Pulmonary hypertension, n (%)           0             21 (22.8)       0.0026
  VC, % predicted                     86.1 ± 2.6        82.7 ± 2.2        NS
  FEV~1~, % predicted                 73.3 ± 3.3        63.5 ± 2.3       0.023
  FEV~1~/VC %                        61.63 ± 2.5        56.4 ± 1.5        NS
  MEF~50~, % predicted                30.8 ± 3.4        26.6 ± 2.3        NS
  CRP, mg/l                           4.1 ± 0.7         8.2 ± 1.0        0.018

###### 

Results of linear regression analysis for predictors of cardiovascular disease in the overall patients 65 years old or more

  **Asthma + COPD**    **Non standardized coefficients**   **Standardized coefficient**   **t**   **Sig.**  
  ------------------- ----------------------------------- ------------------------------ ------- ---------- ------
  CVD                                                                                                          
  Constant                           .879                              .421                        2.087     .040
  Age                                .020                              .006               .380     3.581     .001
  VC, % predicted                    −.005                             .002               −.308    −2.813    .006
  CRP                                −.006                             .003               −.190    −1.707    .092
  Pressure overload                                                                                            
  Constant                           .895                              .328                        2.731     .008
  Sex                                .217                              .094               .255     2.310     .024
  BMI                                .022                              .011               .226     2.047     .044
  Volume overload                                                                                              
  Constant                           .293                              .874                         .335     .739
  Age                                .024                              .011               .229     2.091     .040
  VC, % predicted                    −.006                             .003               −.207    −1.883    .063

###### 

Results of linear regression analysis for predictors of cardiovascular disease in asthmatic patients 65 years old or more

  **Asthma**           **Non standardized coefficients**   **Standardized coefficient**   **t**    **Sig.**  
  ------------------- ----------------------------------- ------------------------------ -------- ---------- ------
  CVD                                                                                                           
  Constant                           7.203                             .662                         10.885    .000
  VC, % pred                         −.058                             .007               −2.909    −8.345    .000
  FEV~1~, % pred                     .064                              .008               4.069     7.728     .000
  FEV~1~/VC, %                       −.084                             .011               −3.472    −7.509    .000
  Pressure overload                                                                                             
  Constant                           3.616                            1.487                         2.432     .035
  Age                                .028                              .015                .250     1.913     .085
  Sex                                .864                              .152                .864     5.691     .000
  GINA class                         −.380                             .138               −.629     −2.766    .020
  VC, % pred                         −.032                             .010               −1.209    −3.306    .008
  FEV~1~, % pred                     .033                              .012               1.566     2.661     .024
  FEV~1~/VC, %                       −.043                             .015               −1.333    −2.785    .019
  PaO~2~                             −.017                             .006               −.392     −2.954    .014
  Volume overload                                                                                               
  Constant                           .293                              .874                          .335     .739
  Age                                .024                              .011                .229     2.091     .040

###### 

Results of linear regression analysis for predictors of cardiovascular disease in COPD patients 65 years old or more

  **COPD**             **Non standardized coefficients**   **Standardized coefficient**   **t**   **Sig.**  
  ------------------- ----------------------------------- ------------------------------ ------- ---------- ------
  CVD                                                                                                          
  Constant                           .542                              .464                        1.169     .247
  Age                                .018                              .006               .373     3.259     .002
  BMI                                .011                              .006               .200     1.748     .085
  VC,% predicted                     −.003                             .002               −.198    −1.724    .090
  Pressure overload                                                                                            
  Constant                           1.110                             .330                        3.366     .001
  BMI                                .025                              .012               .263     2.060     .044
  Volume overload                                                                                              
  Constant                           .928                              .480                        1.932     .058
  Sex                                .384                              .148               .341     2.598     .012
  Smoking                            .289                              .112               .339     2.576     .013
  VC, % predicted                    −.006                             .004               −.212    −1.763    .083

Discussion
==========

The results of this study show that patients with chronic airway obstructive disorders, either asthma or COPD, have increased prevalence of cardiovascular diseases as compared to the general population of similar age \[[@B18]\]. The comparison between the two disorders, (see Table [1](#T1){ref-type="table"}) showed that CVD, particularly with volume overload, was more frequent in COPD patients, who had also older age, higher BMI, heavy smoking history, increased CRP and greater airway obstruction. This finding is in agreement with prior observations that in COPD comorbidities are frequent and are sustained by systemic inflammation and by smoking \[[@B4],[@B6],[@B7]\]. The comparison among patients without CVD, with PO and VO, showed that both pressure and volume overload were associated with older age and increased airway obstruction, either in asthma or in COPD, (see Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}). These findings are in agreement with prior observations in COPD \[[@B8]-[@B13],[@B19]\]. Unfortunately, relatively little research has been done in asthma \[[@B14]\]. It is generally believed that the link between asthma and CVD is less strong than that for COPD \[[@B14],[@B20],[@B21]\] and this applies particularly to ischemic heart disease in asthmatic males. By contrast, in women adult-onset asthma has been found to be a significant risk factor for IHD and stroke \[[@B21],[@B22]\]. Although only 8 of our asthmatic patients had IHD, as many as 6 of them (75%) were never smoking women. However, the strongest predictors of IHD were COPD, age, BMI and FEV~1~, as previously suggested \[[@B19],[@B23]\]. The strong association of COPD with IHD is attributed to the effect of cigarette smoking \[[@B19]-[@B24]\], and about 90% of our COPD patients were past or present smokers. The subanalysis of COPD patients with predominant chronic bronchitis or emphysema, (see Table [9](#T9){ref-type="table"}), showed that the emphysema phenotype was associated with older age, lower BMI, more severe airway obstruction and higher prevalence of pulmonary hypertension and of volume overload. Unfortunately, there are no data in the literature comparing CVD in the two COPD phenotypes.

As mentioned above, age and COPD were the strongest predictors of CVD, but the two factors were closely linked each other, as COPD patients were significantly older than asthmatics. To clarify this point, we performed a sub-analysis on patients with an age equal to or higher than 65 years. As shown in Table [10](#T10){ref-type="table"}, older asthmatics had the same prevalence of CVD than COPD patients (91% versus 95%). However, also in the elderly, the prevalence of IHD and PH was higher in COPD. Pulmonary hypertension deserves a special comment. PH in COPD is classically attributed to severe hypoxia causing raised pulmonary pressures, but other factors such as endothelial dysfunction or left heart disease, are deemed to play a role \[[@B24]\]. In our patients, the predictors of PH were FEV~1~ and volume overload, suggesting that both airway obstruction and post capillary mechanisms participated in increased pulmonary vascular resistance. Actually, VO was present in 80% of patients with PH.

Conclusions
===========

In conclusion, the results of this study indicate that cardiovascular disease are frequent in patients with chronic obstructive disorders, particularly COPD. The strongest predictors of CVD are age and severity of airway obstruction. In older patients the prevalence of CVD is similar in asthma and COPD, apart from ischemic heart disease and pulmonary hypertension, which are strongly associated with COPD.
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